Can salbutamol (albuterol) cause serious adverse effects in a 1-year-old child with a cough?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Salbutamol (Albuterol) Safety in 1-Year-Old Children with Cough

Salbutamol (albuterol) can potentially cause serious adverse effects in a 1-year-old child with cough and should not be routinely used for non-specific cough in this age group. 1

Risks and Adverse Effects

Salbutamol, like other beta-2 agonists, can cause several concerning adverse effects in young children:

  • Cardiovascular effects: Tachycardia (7% incidence) 2
  • Neurological effects: Nervousness (7%), hyperkinesia, tremor 2
  • Gastrointestinal effects: Nausea (10%), vomiting (7%) 2
  • Other potential effects: Metabolic acidosis, hypertension, central nervous system stimulation, insomnia, headache 2

In rare cases, more serious adverse reactions can occur:

  • Urticaria
  • Angioedema
  • Bronchospasm (paradoxical)
  • Oropharyngeal edema 2

Evidence Against Use for Non-Specific Cough

The American College of Chest Physicians (ACCP) guidelines specifically state that "there is no evidence to support using β2-agonists in children with acute cough and no evidence of airflow obstruction." 1 The guidelines further note that there has been only one study on the use of inhaled salbutamol for chronic cough, which showed no benefit.

A Cochrane review confirmed that in children presenting with isolated chronic cough, there was no significant difference between salbutamol-treated groups and placebo groups in reducing cough frequency measured either objectively or scored subjectively. 3

Limited Appropriate Indications

Salbutamol may be appropriate in specific circumstances:

  1. Children with URI undergoing anesthesia: In children under age 6 with upper respiratory infections (URI) who are undergoing general anesthesia, salbutamol nebulization 30 minutes before induction may reduce perioperative respiratory adverse events. 1, 4

  2. Children with evidence of bronchospasm: If the child has wheezing or other evidence of bronchospasm, salbutamol might be considered. 1

  3. Children with post-prematurity respiratory disease: These children may benefit from bronchodilators, though response is variable. 1

Recommendations for 1-Year-Old with Cough

For a 1-year-old child with cough:

  1. Avoid salbutamol unless specific indications exist: Do not use for non-specific cough without evidence of bronchospasm or airflow obstruction. 1

  2. Avoid OTC cough medications: The ACCP guidelines advise against using over-the-counter cough medications in young children, as they have little benefit and potential for harm. 1

  3. Consider underlying causes: Evaluate for specific etiologies of cough that may require targeted treatment (e.g., bacterial infection, asthma with clear evidence of airflow obstruction).

Common Pitfalls to Avoid

  • Misdiagnosing non-specific cough as asthma: Even if cough resolves with asthma treatment, this doesn't necessarily mean the child has asthma. 1

  • Increasing doses when ineffective: If cough is unresponsive to initial treatment with inhaled corticosteroids, increasing the dose is not recommended. 1

  • Prolonged use without reassessment: If a trial of asthma therapy is warranted, reassessment should occur after 2-3 weeks. 1

In summary, while salbutamol has specific uses in pediatric respiratory care, it should not be routinely prescribed for a 1-year-old with cough due to potential serious adverse effects and lack of evidence for efficacy in non-specific cough.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Inhaled beta2-agonists for treating non-specific chronic cough in children.

The Cochrane database of systematic reviews, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.